Li Ping Wang
Director/Board Member at Sichuan Jinxin Fertility Medical Management Co., Ltd.
Profile
Li Ping Wang has held director positions at Shenzhen Zhongshan Urological Hospital and Sichuan Jinxin Fertility Medical Management Co., Ltd.
Li Ping Wang active positions
| Companies | Position | Start |
|---|---|---|
Sichuan Jinxin Fertility Medical Management Co., Ltd.
 Sichuan Jinxin Fertility Medical Management Co., Ltd. Medical/Nursing ServicesHealth Services Sichuan Jinxin Fertility Medical Management Co., Ltd. operates fertility centers. The company was founded on September 12, 2016 and is headquartered in Chengdu, China. | Director/Board Member | - |
Shenzhen Zhongshan Urological Hospital
 Shenzhen Zhongshan Urological Hospital Medical/Nursing ServicesHealth Services Part of Sichuan Jinxin Reproductive Medical Investment Management Co, Shenzhen Zhongshan Urological Hospital is a hospital specializing in urological treatments. The hospital is based in Shenzhen, China. The hospital has a strong focus on research, with 42 research projects and 264 clinical trials currently ongoing. The Chinese company was founded in 1986 and has since expanded to include 351 beds, with 71 of them being in intensive care. The CEO is Jiang Lin Deng. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Sichuan Jinxin Fertility Medical Management Co., Ltd.
Sichuan Jinxin Fertility Medical Management Co., Ltd. Medical/Nursing ServicesHealth Services Sichuan Jinxin Fertility Medical Management Co., Ltd. operates fertility centers. The company was founded on September 12, 2016 and is headquartered in Chengdu, China. | Health Services |
Shenzhen Zhongshan Urological Hospital
Shenzhen Zhongshan Urological Hospital Medical/Nursing ServicesHealth Services Part of Sichuan Jinxin Reproductive Medical Investment Management Co, Shenzhen Zhongshan Urological Hospital is a hospital specializing in urological treatments. The hospital is based in Shenzhen, China. The hospital has a strong focus on research, with 42 research projects and 264 clinical trials currently ongoing. The Chinese company was founded in 1986 and has since expanded to include 351 beds, with 71 of them being in intensive care. The CEO is Jiang Lin Deng. | Health Services |
- Stock Market
- Insiders
- Li Ping Wang
